2016
DOI: 10.1210/jc.2016-1932
|View full text |Cite
|
Sign up to set email alerts
|

Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin

Abstract: Context:Metastatic disease is responsible for the majority of endocrine cancer deaths. New therapeutic targets are urgently needed to improve patient survival rates.Objective:The proto-oncogene PTTG1-binding factor (PBF/PTTG1IP) is overexpressed in multiple endocrine cancers and circumstantially associated with tumor aggressiveness. This study aimed to understand the role of PBF in tumor cell invasion and identify possible routes to inhibit its action.Design, Setting, Patients, and Interventions:Thyroid, breas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
12
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 40 publications
(77 reference statements)
1
12
0
Order By: Relevance
“…For example, enhanced PBF levels potentially lead to cell invasion in breast cancer. In addition, PBF potentially elicits cell migration and invasion in thyroid cancer and hepatocellular carcinoma [24,25]. Moreover, PBF is associated with tumor recurrence, and its subcutaneous expression contributes to tumor formation in nude mice [22,25].…”
Section: Discussionmentioning
confidence: 99%
“…For example, enhanced PBF levels potentially lead to cell invasion in breast cancer. In addition, PBF potentially elicits cell migration and invasion in thyroid cancer and hepatocellular carcinoma [24,25]. Moreover, PBF is associated with tumor recurrence, and its subcutaneous expression contributes to tumor formation in nude mice [22,25].…”
Section: Discussionmentioning
confidence: 99%
“…2010 ). More recent investigations have demonstrated that PBF can induce invasion and migration in multiple cancer cells including thyroid and colorectal cells ( Watkins et al . 2016 ).…”
Section: Resultsmentioning
confidence: 99%
“…2016 ). Furthermore, these studies suggest that this occurs at least partly through interaction with cortactin (CTTN), a scaffold protein that acts predominantly at the cell periphery to promote actin polymerisation and can thus exert a potent influence upon cell movement and invasion ( Watkins et al . 2016 ).…”
Section: Resultsmentioning
confidence: 99%
“…Overexpression of Cortactin is frequently observed in many types of cancers, including head and neck squamous cell carcinoma (HNSCC), 96 hepatocellular carcinoma, 97 breast cancer, 98 bladder cancer, 99 renal cell carcinoma, 100 esophageal squamous cell carcinoma, 101 colorectal adenocarcinoma, 102 melanoma, 103 osteosarcoma, 104 prostate cancer, 105 non-small cell lung cancer, 106 glioma, 107 epithelial ovarian cancer, 108 thyroid cancer 109 and B-cell chronic lymphocytic leukemia. 110 This overexpression is partially caused by the amplification of chromosome 11q13 where the CTTN gene is located.…”
Section: Cortactin In Cancermentioning
confidence: 99%
“…A major conclusion from clinical studies is that Cortactin overexpression is associated with local invasion, lymph node metastasis and/or distal metastasis in almost every cancer in which it is overexpressed. 19,96,97,99,101,103,106,109,113 Moreover, several mouse models have provided evidence that Cortactin promotes the metastatic process. 97,101,121 Altogether, these findings indicate that Cortactin plays an important role in promoting tumor invasion and metastasis, consistent with the major role of Cortactin in regulating lamellipodia and invadopodia formation.…”
Section: Cortactin In Cancermentioning
confidence: 99%